{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-21-331994","form_type":"8-K","ticker":"APLS","cik":"0001492422","company_name":"Apellis Pharmaceuticals, Inc.","filed_at":"2021-11-17T23:59:59+00:00","discovered_at":"2026-05-14T18:04:12.729017+00:00","generated_at":"2026-06-28T07:21:08.657541+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Apellis Pharmaceuticals prices $350M public offering of 8.75M shares at $40/share","bullets":["Apellis priced public offering of 8.75M shares at $40.00/share for gross proceeds of $350M.","Underwriters have 30-day option to purchase up to 1.3125M additional shares at the same price less discounts.","Estimated net proceeds of ~$330.2M, or ~$379.8M if underwriters fully exercise option.","Offering expected to close Nov. 18, 2021; J.P. Morgan, Goldman Sachs, Evercore are joint book-running managers."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-21-331994","json":"https://secwatch.observer/filing/0001193125-21-331994.json","markdown":"https://secwatch.observer/filing/0001193125-21-331994.md","text":"https://secwatch.observer/filing/0001193125-21-331994.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1492422/000119312521331994/0001193125-21-331994-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1492422/000119312521331994/d222547d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T07:21:08.657541+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}